Senna by Kesin Pharma Corporation

Senna by

Drug Labeling and Warnings

Senna by is a Otc medication manufactured, distributed, or labeled by Kesin Pharma Corporation. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

SENNA- sennosides syrup 
Kesin Pharma Corporation

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Active ingredient (in each 5mL teaspoonful)

Sennosides 8.8mg

Laxative

Stop use and ask a doctor if you have rectal bleeding or failure to have a bowel movement after use of a laxative.

These may indicate a serious condition.

In case of accidental overdose, get medical help or contact a Poison Control Center immediately.

If pregnant or breastfeeding, ask a health professional before use.

• Ask a doctor before use if you have stomach pain, nausea or vomitting
• Noticed a change in bowel habits over two weeks

Do not use laxative products for longer than one week unless directed by a doctor

Questions or Comments? 833-537-4679

Age	Starting Dose	Maximum Dose
Adults and children 12 years and older	2 to 3 teaspoonfuls once a day preferably at bedtime; increase as needed or as recommended by a doctor	3 teaspoonfuls in the morning and 3 teaspoonfuls at bedtime
Under 12 years of age	Ask a doctor	Ask a doctor

Artificial and natural chocolate flavor, methylparaben, propylene glycol, propylparaben, purified water, sucrose

Store at room temperature (59-77 degrees F)

Uses

• Relieves ocassional constipation (irregularity)
• Generally causes bowel movement in 6 to 12 hours

PRINCIPAL DISPLAY PANEL

Senna Syrup, USP- 5mL

Senna Syrup, USP 10 mL

Senna Syrup, USP 15 mL

SENNA 
sennosides syrup

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 81033-001
Route of Administration	ORAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
SENNOSIDES (UNII: 3FYP5M0IJX) (SENNOSIDES - UNII:3FYP5M0IJX)	SENNOSIDES	8.8 mg  in 5 mL

Inactive Ingredients
Ingredient Name	Strength
METHYLPARABEN (UNII: A2I8C7HI9T)
WATER (UNII: 059QF0KO0R)
SUCROSE (UNII: C151H8M554)
PROPYLPARABEN (UNII: Z8IX2SC1OH)

Product Characteristics
Color	brown	Score
Shape		Size
Flavor	CHOCOLATE	Imprint Code
Contains

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 81033-001-51	8 in 1 CASE	03/10/2021	12/14/2022
1	NDC: 81033-001-50	50 in 1 BOX
1	NDC: 81033-001-05	5 mL in 1 CUP; Type 0: Not a Combination Product
2	NDC: 81033-001-41	8 in 1 CASE	03/10/2021	12/14/2022
2	NDC: 81033-001-40	40 in 1 BOX
2	NDC: 81033-001-10	10 mL in 1 CUP; Type 0: Not a Combination Product
3	NDC: 81033-001-43	8 in 1 CASE	03/10/2021	12/14/2022
3	NDC: 81033-001-42	40 in 1 BOX
3	NDC: 81033-001-15	15 mL in 1 CUP; Type 0: Not a Combination Product

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC monograph not final	part334	03/10/2021	12/14/2022

Labeler - Kesin Pharma Corporation (117447816)

Revised: 9/2023

Document Id: eb886e12-b8b8-4fb1-8b9f-57304bbb86cb

34390-5

Set id: bce214bc-958c-4e45-e053-2995a90acda5

Version: 4

Effective Time: 20230927